AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on October 27, 2026

Western New England Bancorp, Inc. Reports Results for Three and Nine Months Ended September 30, 2026 and Declares Quarterly Cash Dividend
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
Praxis Precision Medicines Announces Third Quarter 2026 Financial Results Date, Investor Day and November Conference Participation
Cogent Biosciences to Participate in the Guggenheim Healthcare Innovation Conference
Little Sparrows Technologies Receives Innovative Technology Designation from Vizient for bili-hut™ Neonatal Phototherapy
IDC FutureScape 2027 Predicts 60% of Enterprises Will Run a Majority of Their Business Processes AI-first by 2029, up from 13% in 2026
Agricultural Biotechnology Market to Reach $137.0 Billion by 2031
Lambent Expands Executive Team and Opens London and New York Offices to Meet Growing Enterprise Demand
NetBox Labs and NEYON AI partner to speed AI factory buildouts and cut time to first token
The Gene Lay Institute of Immunology and Inflammation Expands World-Class Research Leadership, Appointing Four New Members
Re:Build Announces $2.1 Billion to Accelerate America's Reindustrialization
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Rocket Software Selects 23 Projects to Compete at Rocket.Build 2026 Finals in London
Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System
Candel Therapeutics to Present at November Investor Conferences
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
Luva Debuts Revolutionary AI-Powered Insurance Comparison Platform
Schneider Electric, Nscale and Start Campus Bring the NVIDIA Omniverse DSX Blueprint into a Live AI Factory Environment
Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.